CIMCALTYX Trademark

Trademark Overview

On Monday, March 4, 2024, a trademark application was filed for CIMCALTYX with the United States Patent and Trademark Office. The USPTO has given the CIMCALTYX trademark a serial number of 98431234. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, March 4, 2024. This trademark is owned by Pathalys Pharma, Inc.. The CIMCALTYX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and biological preparations; Calcimimetics; Pharmaceutical and biological preparations for use in nephrology and endocrinology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing diseases, disorders, and conditions of the kidneys and glands; Pharmaceutical and biological preparations for treating and managing chronic kidney disease (CKD), end stage renal disease (ESRD), secondary hyperparathyroidism (SHPT), and conditions arising from complications of kidney disease and hemodialysis; Therapeutic agents for affecting calcium-sensing receptors on cells and managing calcium levels in the body.
cimcaltyx

General Information

Serial Number98431234
Word MarkCIMCALTYX
Filing DateMonday, March 4, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateMonday, March 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical and biological preparations; Calcimimetics; Pharmaceutical and biological preparations for use in nephrology and endocrinology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing diseases, disorders, and conditions of the kidneys and glands; Pharmaceutical and biological preparations for treating and managing chronic kidney disease (CKD), end stage renal disease (ESRD), secondary hyperparathyroidism (SHPT), and conditions arising from complications of kidney disease and hemodialysis; Therapeutic agents for affecting calcium-sensing receptors on cells and managing calcium levels in the body.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 4, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePathalys Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRaleigh, NC 27609

Trademark Events

Event DateEvent Description
Monday, March 4, 2024NEW APPLICATION ENTERED
Monday, March 4, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

cimcaltyx preparations pharmaceutical biological managing disease treating conditions kidney calcium body